GBE-761

N/A

Report date: 2022/01/17 12:14:22

Base Information

Drug NameGBE-761
Drug Alias NameGingoginkGinkgo biloba special extract - Dr Wilmar Schwabe Group/IpsenTeboninTramisalTanakan +[6] 
ClassificationNatural product/Extract
Mechanisms of ActionNitric oxide synthase, inducible inhibitorsPlatelet aggregation inhibitors
TargetsNitric oxide synthase, inducible
Therapy Area/IndicationsCognition DisordersVascular DiseasesAlzheimer Disease +[7] 
Global Approved IndicationsCognition DisordersVascular DiseasesAlzheimer Disease +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date1975/01/01
Country/TerritoryUnited StatesMexicoFrance
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesDr. Willmar Schwabe Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Guadalajara
Inactive CompaniesIpsenNational Center For Complementary And Integrative Health
Active IndicationsCognition DisordersVascular DiseasesAlzheimer Disease +[5] 
Inactive IndicationsDementiaMultiple Sclerosis, Relapsing-Remitting

Other Information

ATC CodeN/A
Related LinksN/A